Testra's shares fail to make a connection with investors

Article Abstract:

Factors effecting Telstra Corporation's stock value are discussed, including strategic alliances with Pacific Century CyberWorks and perceptions about the Australian government's 50.1% controlling stake.

Australia, Financial analysis, Statistical Data Included

---

Telstra on track for IPO

Article Abstract:

Australia's national telecommunications company, Telstra Inc., is being readied for a partial sale that the government hopes will raise US$6.4 billion. The opposition Labor Party and two other minority parties are against the privatization. The government is trying to win the Senate's approval of the sale plan by wooing two independent senators, promising to earmark a further A$100 million for the environment fund and another A$250 million for a regional infrastructure fund.

Telecommunications, Telephone Communication, Privatization, Privatization (Business)

---

Rash of hot jobs breaks out; surveys indicate some Asian employers have hiring on their minds

Article Abstract:

A growing number of established and start-up firms in some Asian countries are on the lookout for an increasing number of employees, according to recent surveys. Despite the financial slowdown caused by the Asian economic crisis, some companies, especially in the telecommunications, information technology and public relations industries, are increasing their staff count. Aside from skilled, high-caliber managers, these companies are on a particular lookout for marketing and sales executives. Meanwhile, more down-the-line jobs are seen to increase as multinational firms expand to more Asian markets.

Asia, Personnel administration

Similar abstracts:

• Abstracts: Seagram's loss in quarter is held in check by liquor, music units. Seagram expects units to post strong earnings in fiscal 2000
• Abstracts: Ahold seeks to buy U.S. Foodservice in transaction valued at $2.68 billion. Ahold confirms plans to buy Alliant Exchange in stock deal
• Abstracts: Zeneca shareholders to decide Astra deal; few bars remain to creating No. 3 drug firm. Newest ulcer drug from AstraZeneca has a slight edge
• Abstracts: Investors buy Veba, Viag shares despite disappointing earnings. Deutsche Telekom reports higher operating earnings
• Abstracts: Lernout & Hauspie to restate results due to `irregularities.'(Nasdaq, Easdaq suspend trading of tech firm's shares.)

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.